Dr. Eve Lewandowski is an assistant professor in Psychiatry at Harvard Medical School and Director of Clinical Programming for McLean OnTrack first episode clinic. Eve received her PhD in clinical psychology from the University of North Carolina, Greensboro, where she studied cognitive, behavioral, and genetic markers of schizotypy. She completed her postdoctoral fellowship at McLean Hospital/Harvard Medical School prior to joining the faculty. Her program of research centers on cognition and cognitive interventions for people with psychotic disorders. Her federally-funded research has included efficacy and neurobiological outcomes of cognitive remediation in bipolar disorder, computational approaches to characterizing heterogeneity in cognition across the psychoses, and examination of the latent structure of motivation and reward.

She is currently conducting implementation work to translate cognitive remediation into clinical practice, for which she was awarded the 2018 Connie Lieber Science to Practice Award. Eve serves as the Director of the Psychology Doctoral Internship Program Psychotic Disorders training, and provides supervision, training, and mentorship to junior faculty, fellows, residents, and interns.

Dr. Ahmed Moustafa is a Professor of Psychology and Computational Modeling at School of Psychology, Bond University, Gold Coast, Queensland, Australia. Prior to moving to Bond University, Ahmed was an associate professor in Psychology and Neuroscience at Marcs Institute for Brain, Behavior, and Development & School of Psychology, Western Sydney University. Ahmed is trained in computer science, psychology, neuroscience, and cognitive science. His early training took place at Cairo University in mathematics and computer science. Before joining Western Sydney University as a lab director, Ahmed spent 11 years in America working on several psychology and neuroscience projects. Ahmed conducts research on computational and neuropsychological studies of addiction, schizophrenia, Parkinson’s disease, PTSD, depression, Alzheimer’s disease. He has published over 240 papers in high-ranking journals including Science, PNAS, Journal of Neuroscience, Brain, Neuroscience and Biobehavioral Reviews, Nature (Parkinson’s disease), Neuron, among others.